|Videos|March 15, 2017
Kathleen N. Moore Discusses New PARP Inhibitors for Ovarian Cancer
Author(s)Kathleen N. Moore M.D.
Kathleen N. Moore, M.D., assistant professor, Stephenson Cancer Center, The University of Oklahoma, discusses developing new PARP inhibitors for patients with ovarian cancer. These new drugs may meaningfully prolong survival from a couple months to potentially years.
Advertisement
Kathleen N. Moore, M.D., assistant professor, Stephenson Cancer Center, The University of Oklahoma, discusses developing new PARP inhibitors for patients with ovarian cancer. These new drugs may meaningfully prolong survival from a couple months to potentially years.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
How A Cancer Vaccine and Keytruda Work to Treat Patients With Melanoma
2
Cancer Vaccine Plus Keytruda Reduces Melanoma Recurrence or Death
3
Pancreatic Cancer Treatment Options and Strategies for Patients
4
How Ikebana Helped Me Navigate Life With Cancer
5